These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9253535)

  • 1. Obesity and cardiovascular disease: is body structure a factor?
    Nielsen S; Jensen MD
    Curr Opin Lipidol; 1997 Aug; 8(4):200-4. PubMed ID: 9253535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of obesity: the need to target attention on high-risk patients characterized by abdominal obesity].
    Scarsella C; Després JP
    Cad Saude Publica; 2003; 19 Suppl 1():S7-19. PubMed ID: 12886431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is visceral obesity the cause of the metabolic syndrome?
    Després JP
    Ann Med; 2006; 38(1):52-63. PubMed ID: 16448989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upper body adiposity and the risk for atherosclerosis.
    Van Gaal LF; Vansant GA; De Leeuw IH
    J Am Coll Nutr; 1989 Dec; 8(6):504-14. PubMed ID: 2695550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity.
    Lemieux I; Pascot A; Prud'homme D; Alméras N; Bogaty P; Nadeau A; Bergeron J; Després JP
    Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):961-7. PubMed ID: 11397704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Visceral fat].
    Nakamura T; Matsuzawa Y
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():699-705. PubMed ID: 12355836
    [No Abstract]   [Full Text] [Related]  

  • 7. Dietary carbohydrates in lipid disorders in man.
    Albrink MJ
    Prog Biochem Pharmacol; 1973; 8():242-70. PubMed ID: 4597900
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin resistance, impaired postprandial lipid metabolism and abdominal obesity. A deadly triad.
    Frayn KN
    Med Princ Pract; 2002; 11 Suppl 2():31-40. PubMed ID: 12444308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between obesity and the increased risk of major complications in non-insulin-dependent diabetes mellitus.
    Serrano Rios M
    Eur J Clin Invest; 1998 Sep; 28 Suppl 2():14-7, discussion 17-8. PubMed ID: 9777322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hyperuricemia as a unique marker for metabolic syndrome].
    Nakajima H
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():269-73. PubMed ID: 15779385
    [No Abstract]   [Full Text] [Related]  

  • 11. Improvement of glucose and lipid metabolism associated with selective reduction of intra-abdominal visceral fat in premenopausal women with visceral fat obesity.
    Fujioka S; Matsuzawa Y; Tokunaga K; Kawamoto T; Kobatake T; Keno Y; Kotani K; Yoshida S; Tarui S
    Int J Obes; 1991 Dec; 15(12):853-9. PubMed ID: 1794928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abdominal obesity and its metabolic complications: implications for the risk of ischaemic heart disease.
    Lamarche B
    Coron Artery Dis; 1998; 9(8):473-81. PubMed ID: 9847978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of large-volume liposuction on metabolic risk factors for coronary heart disease.
    Mohammed BS; Cohen S; Reeds D; Young VL; Klein S
    Obesity (Silver Spring); 2008 Dec; 16(12):2648-51. PubMed ID: 18820648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of obesity and consequent insulin resistance on coronary risk factors in medically treated patients with coronary disease.
    Ades PA; Savage PD; Toth MJ; Schneider DJ; Audelin MC; Bunn JY; Ludlow M
    Int J Obes (Lond); 2008 Jun; 32(6):967-74. PubMed ID: 18268512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial.
    Ross R; Dagnone D; Jones PJ; Smith H; Paddags A; Hudson R; Janssen I
    Ann Intern Med; 2000 Jul; 133(2):92-103. PubMed ID: 10896648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Visceral adipose tissue and metabolic syndrome].
    Blüher M; Paschke R
    Dtsch Med Wochenschr; 2003 Oct; 128(44):2319-23. PubMed ID: 14593576
    [No Abstract]   [Full Text] [Related]  

  • 17. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat.
    Nieves DJ; Cnop M; Retzlaff B; Walden CE; Brunzell JD; Knopp RH; Kahn SE
    Diabetes; 2003 Jan; 52(1):172-9. PubMed ID: 12502509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of smoking on lipid parameters during therapeutic weight loss.
    Van Gaal LF; De Leeuw IH
    Atherosclerosis; 1986 Jun; 60(3):287-90. PubMed ID: 3730048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Visceral fat obesity].
    Tarui S
    Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1547-53. PubMed ID: 8245658
    [No Abstract]   [Full Text] [Related]  

  • 20. Visceral fat accumulation contributes to insulin resistance, small-sized low-density lipoprotein, and progression of coronary artery disease in middle-aged non-obese Japanese men.
    Kobayashi H; Nakamura T; Miyaoka K; Nishida M; Funahashi T; Yamashita S; Matsuzawa Y
    Jpn Circ J; 2001 Mar; 65(3):193-9. PubMed ID: 11266194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.